Carregant...
The MINDACT trial: The first prospective clinical validation of a genomic tool
One of the main challenges in oncology today has become to distinguish accurately between those patients who need adjuvant treatment and those who do not. This, together with the identification of the best type of therapy for the individual patient and the development of drugs targeting specific cha...
Guardat en:
| Publicat a: | Mol Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5543876/ https://ncbi.nlm.nih.gov/pubmed/19383299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2007.10.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|